Coronary Physiology in STEMI patients today: Why? When? How?

Published: 08 April 2022

  • Views:

    Views Icon 739
  • Likes:

    Heart Icon 7

Overview

Physiology in STEMI patients is a controversial hot topic in interventional cardiology: it has been first demonstrated to enhance the benefits of full revascularization vs PCI only in the culprit lesion; then its effectiveness has been mitigated by clinical outcomes not showing any differences versus angiography-guided complete revascularization.


Join a panel of international expert in the discussion about a topic that is still controversial and may impact a large number of STEMI patients undergoing PCI.

Clinical evidence and cases from the real world will be the two key subjects debated during the breakout session at TIO 2022.

This video series page is supported by

Key Learning Objectives

  • To understand the current position of Key Opinion Leaders on physiology in STEMI patients
  • To actively participate to the debate over the options offered in the cathlab to support physiology guided complete revascularization in STEMI patients
  • To review the literature and defining the key clinical settings where physiology should play a role in the decision making

Target Audience

  • Interventional Cardiologists
  • Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional Cardiology Nurses

More from this programme

Part 1

Coronary Physiology in STEMI Patients Today: Why? When? How?

Watch a panel of international expert in the discussion about a topic that is still controversial and may impact a large number of STEMI patients undergoing PCI.

Part 2

Coronary Physiology in Diffuse Disease

Watch this on-demand broadcast from January 2022, where expert Interventional Cardiologists sharing their experience on their decision making process in patients with diffuse disease and the clinical role of coronary physiology in driving their PCI strategy.

Faculty Biographies

Joost Daemen

Joost Daemen

Interventional cardiologist

Dr Joost Daemen, MD, PhD obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam. 

Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of 4 trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

View full profile